As global health threats continue to evolve rapidly, pharmaceutical leaders face mounting pressure to design development programs that can withstand volatility. From pandemics to geopolitical unrest ...

The Pharmaceutical Sciences, Pharmaceutical Marketing and Management Option is perfect for students interested in careers that integrate science and business for a rewarding career in the ...

The latest update is out from Daito Pharmaceutical Co., Ltd. ( ($JP:4577) ). Daito Pharmaceutical Co., Ltd., a Japan-based pharmaceutical company ...

In today’s Pharmaceutical Executive Daily, President Trump announces nine additional participants in the TrumpRx program, ...

Company to Prioritize Clinical Development of Tacrolimus Inhalation Powder (TFF TAC) based on Positive Phase 2 Data, the Potential to Address a Significant Unmet Need in Lung Transplant Medicine and ...

AUGUSTA, Maine (WABI) - Members of The Coalition to Protect Health Care for Rural and Underserved Communities met at the State House Wednesday to ask lawmakers to support a bill they say will protect ...

Over the past year, Democrats in Washington have begun to level the playing field between healthcare special interests like Big Pharma manufacturers and regular Americans, especially those most in ...

- Aligned with FDA on operationally seamless Phase 2/3 trial for Actimab-A + CLAG-M in relapsed/refractory acute myeloid leukemia - Actimab-A selected for National Cancer Institute's recently opened ...

TORONTO--(BUSINESS WIRE)--Conscience, a non-profit focused on accelerating drug discovery in areas of unmet medical need using open science and radical collaboration, is pleased to announce three ...

Kiriayani Diaz remembers wanting to be a pediatrician when she was growing up. But as high school graduation approached in early 2021, she was undecided about which career path she wanted to take, and ...

NEW YORK, December 08, 2025--(BUSINESS WIRE)--Hercules Pharmaceuticals (Hercules), a national leader in pharmaceutical distribution, today announced that it has been approved as an authorized ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) released results from a neurotoxicity study of Ketamir-2, its novel oral NMDA receptor antagonist, on Tuesday. The U.S. Food and Drug Administration (FDA) ...